Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications (Q35141566)

6 August 2017

Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications (English)

1 reference

6 August 2017

Sebastian Schneeweiss

series ordinal

6

object named as

Sebastian Schneeweiss

1 reference

6 August 2017

2

William H Shrank

1 reference

6 August 2017

4

Jerry Avorn

1 reference

6 August 2017

9

Niteesh K Choudhry

1 reference

6 August 2017

8

Troyen A Brennan

1 reference

6 August 2017

1

Nihar R Desai

1 reference

6 August 2017

7

Juliana Pakes

1 reference

6 August 2017

Michael A Fischer

3

1 reference

PubMed ID

22340932

6 August 2017

Joshua N Liberman

series ordinal

5

1 reference

PubMed ID

22340932

6 August 2017

language of work or name

English

0 references

publication date

1 March 2012

1 reference

American Journal of Medicine

6 August 2017

1 reference

6 August 2017

125

1 reference

6 August 2017

302.e1-7

1 reference

6 August 2017

3

1 reference

Regulatory action on rosiglitazone by the U.S. Food and Drug Administration

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347833

Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347833

Patients' perceptions of generic medications

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347833

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347833

Economic costs of diabetes in the U.S. In 2007.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347833

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347833

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347833

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347833

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347833

Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347833

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4347833

Four-dollar generics--increased accessibility, impaired quality assurance

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22340932

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.AMJMED.2011.07.033

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

PubMed ID

22340932